Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168191 · ClinicalTrials.gov registry record · Phase 1
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT03168191 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 56 participants.
The verdict
NCT03168191, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study is to examine if inhaled doses of an e-cigarette flavor, alone and in combination with menthol, changes the appeal of e-cigarettes containing low and high doses of nicotine. The hypothesis is that menthol and the other experimental flavor will interact with nicotine dose to improve taste and liking for e-cigarettes.
Interventions
- DRUG Nicotine
- OTHER Experimental Flavor
- OTHER Menthol Flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2019-02-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03168191
The ClinicalTrials.gov registry entry for NCT03168191 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine is the first listed.
NCT03168191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03168191 about?
NCT03168191 is a clinical study titled "Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2". This study is to examine if inhaled doses of an e-cigarette flavor, alone and in combination with menthol, changes the appeal of e-cigarettes containing low and high doses of nicotine. The hypothesis is that menthol and the other experimental flavor will interact with nicotine dose to improve taste ...
What is the current status of trial NCT03168191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2017-05-02. Estimated completion is 2019-02-25.
What interventions are being tested in trial NCT03168191?
The interventions under investigation include: Nicotine (DRUG), Experimental Flavor (OTHER), Menthol Flavor (OTHER).
Who is sponsoring clinical trial NCT03168191?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.